Technology | 2016.04.13
Another Gene-Editing IPO - The Scientist
| The Scientist | Another Gene- Editing IPO The Scientist Another Gene- Editing IPO. Intellia Therapeutics, which seeks to develop CRISPR-based technologies to target rare diseases, is hoping to raise $120 million in an initial public offering. By Bob Grant | April 12, 2016. WIKIMEDIA, ERNESTO DEL AGUILA III, ... Gene- Editing Company Intellia Discloses IPO Plan, Regeneron Pact One Thing that Could Stop the Rise of Gene Editing : Insurance Companies Gene- editing biotech Intellia files for $120 million IPO |
For more information, please visit
http://news.google.com/news/url?sa=t&fd=[...]eNo/45812/title/Another-Gene-E
